Three important genetic events drive the development of GBM: the dysregulation of growth factor signaling (EGF, PDGF, VEGF, etc.), the activation of the phosphatidylinositol-3-OH-kinase (PI(3)K) pathway and the inactivation of the p53 and retinoblastoma (Rb) tumor suppressor pathways [15]. Here, VEGFA is linked to glioblastoma.